U.S. Healthcare Services Stock News

Earlier in May 2026, Duos Technologies Group, Inc. reported first-quarter 2026 results showing revenue of US$2.72 million, a widening net loss of US$3.49 million, and then reaffirmed its expectation for full-year 2026 revenue to exceed US$50 million while also planning a presentation at the Craig-Hallum 23rd Annual Institutional Investor Conference in Minneapolis on May 28, 2026. This combination of weaker quarterly performance, reiterated full-year revenue ambitions, and outreach to...

If you are wondering whether Avis Budget Group's share price still offers value after past gains or if most of the upside is already reflected, this article walks through what the current valuation might be telling you. The stock last closed at US$165.10, with returns of 8.0% over the past week, down 11.7% over the past month, up 28.8% year to date, and up 37.0% over the last year. Recent share price moves have kept investor attention on how the market is pricing in Avis Budget Group's...

In May 2026, Ingram Micro Holding Corporation announced it had been selected as a Global Distributor for HPE, gaining access to HPE’s entire networking, cloud, and AI portfolio and extending its HPE Partner Growth Accelerator Program worldwide. This expanded relationship deepens Ingram Micro’s role in enterprise infrastructure by pairing full HPE portfolio access with its Xvantage digital platform and global HPE‑focused teams. Next, we’ll examine how becoming one of only two global HPE...

Synopsys (NasdaqGS:SNPS) has appointed Jesse Cohn, a partner at Elliott Management, to its Board of Directors. The appointment comes as part of a new cooperation agreement between Synopsys and Elliott Management that includes board representation and voting commitments. This is the first major corporate governance adjustment at Synopsys in recent periods that brings an activist investor directly into the boardroom. Synopsys enters this governance shift with its shares at $525.92 and multi...

Reddit (NYSE:RDDT) has entered a major content licensing agreement with Google to supply data for Gemini AI models. The company is also in talks with Google and OpenAI about using AI driven pricing for future data licensing deals. This marks a new phase in Reddit's efforts to monetize its vast archive of user generated content. For investors watching NYSE:RDDT, the focus has often been on competition, regulatory issues, and insider activity. This new licensing push opens a different...

Investors may be wondering if Agnico Eagle Mines at about US$174.91 per share is still offering value after a strong run, or if most of the opportunity is already reflected in the price. The stock has slipped about 1.8% over the last week and 11.7% over the last month, yet it is still up 2.6% year to date and 49.9% over the past year, with a very large 3 year return and a 172.9% return over 5 years. This hints at how sentiment around the stock has shifted over time. These moves sit against a...

If you are wondering whether General Motors at US$84.12 is still reasonably priced after a strong run, the starting point is understanding what you are actually paying for today. The stock has returned 10.5% over the last 7 days, 7.9% over the past month, 3.9% year to date and 76.6% over the last year, with a 167.8% return over 3 years and 46.5% over 5 years. Recent coverage around General Motors has focused on how investors are reassessing established automakers in light of shifts in...

Valley National Bancorp (VLY) has been drawing fresh attention after a period of relatively steady trading, with the stock up around 1% over the past month and about 2% over the past 3 months. See our latest analysis for Valley National Bancorp. With the share price at $13.64, Valley National Bancorp’s recent 2.1% 7 day share price return and 16.7% year to date share price return sit alongside a 62.5% 1 year total shareholder return. This suggests momentum has been building over the past year...

Hesai Group (HSAI) is back in focus after announcing a new design win exceeding 1 million lidar units with a top tier European automaker, alongside recent profitability and revenue guidance pointing to higher second quarter sales. See our latest analysis for Hesai Group. Despite the new design win and recent earnings guidance, Hesai Group’s share price has been under pressure, with the stock down 24.29% on a 90 day share price return and 14.33% year to date, while the 3 year total shareholder...

Helix Partners Management LP has fully exited its stake in Cinemark Holdings (NYSE:CNK), according to recent SEC filings. The move removes one institutional investor from Cinemark’s shareholder base and may influence how some investors view the stock. Cinemark operates movie theatres, giving it direct exposure to box office trends, content release schedules, and changing consumer habits. The exit by Helix comes at a time when the theatre industry continues to adjust to streaming...

Nexa Resources (NYSE:NEXA) has proposed amendments to its Articles of Association. Shareholders are scheduled to vote on the changes at the 2026 Annual General Meeting and Extraordinary General Meeting on June 25, 2026. The proposed amendments relate to core governance rules that can affect shareholder rights and future corporate decisions. Nexa Resources, trading at $14.51, has seen its share price rise 65.1% year to date and 196.9% over the past year, with a 194.5% return over three...

In May 2026, Monte Rosa Therapeutics reported encouraging Phase 1/2 data for MRT-2359 in metastatic castration-resistant prostate cancer and shared new preclinical findings for MRT-55811 showing tumor regression across several cancer models. At the same time, director Anthony M. Manning exercised options and sold US$180,100 of stock, a routine move that contrasts with the company’s recent scientific progress. Next, we’ll examine how these early-stage oncology results, especially the...

Box (BOX) opened Q1 2027 with total revenue of US$305.9 million and basic EPS of US$0.09 on net income of US$11.9 million, setting a measured tone for the new fiscal year. Over the past five reported quarters, revenue has moved from US$276.3 million in Q1 2026 to US$305.9 million in Q1 2027, while basic EPS has ranged from US$0.02 to US$0.48, giving investors a clear view of how the top line and per share earnings have tracked through recent periods. With trailing net profit margins below...

Investors may be wondering whether Ingredion at around US$103.96 is starting to look like a bargain, or if the recent slide is a signal to be cautious. The stock has risen 3.2% over the past week, but is down 8.0% over the last 30 days, 5.3% year to date, and 22.6% over the past year. This may reflect shifting views on its growth potential and risk. Recent coverage has focused on how Ingredion fits into broader conversations about consumer demand trends and cost pressures in the food...

Ooma (OOMA) has kicked off Q1 2027 with revenue of about US$81.1 million and basic EPS of roughly US$0.09, alongside net income of around US$2.6 million. This sets a clear earnings tone for the new fiscal year. The company has seen quarterly revenue move from about US$65.0 million and a small net loss in Q1 2026 to roughly US$81.1 million and a net profit of around US$2.6 million in Q1 2027. Trailing twelve month EPS sits at about US$0.33 on revenue of roughly US$289.7 million, so the latest...

HNI (HNI) has drawn fresh attention after issuing 2026 earnings guidance that calls for net sales growth, along with a quarterly dividend declaration and a lower fair value update from analysts. See our latest analysis for HNI. Recent announcements, including 2026 earnings guidance, a US$0.35 quarterly dividend and new product launches such as Allsteel’s Flourish chair, come after a share price that is up 0.8% over one day and 3.8% over seven days but down 16.0% over 30 days and 30.6% over 90...

Agora (API) has reported Q1 2026 revenue of US$37.7 million and net income of US$1.1 million, equal to basic EPS of US$0.01, which follows a year where trailing twelve month revenue reached US$145.5 million and EPS came in at US$0.11. Over recent quarters the company has seen revenue move from US$33.3 million in Q1 2025 to US$38.2 million in Q4 2025 and EPS shift from US$0.00 to US$0.05 over the same period, providing a clearer view of how both top line and per share profitability have been...

Q32 Bio Inc. recently entered into a securities purchase agreement to raise US$55,000,000 through a private placement of 6,725,000 common shares at US$8.00 each and pre-funded warrants for 150,000 shares at US$7.9999, with closing expected on May 28, 2026, subject to customary conditions. The round is led by BVF Partners L.P. with participation from RA Capital Management, OrbiMed, and Atlas Venture, highlighting strong institutional interest in funding Q32 Bio’s development plans. Next,...

Recent performance and business snapshot Pony AI (PONY) has drawn investor attention after a period where the stock rose 4.3% over the past day and 11.4% over the past week, while declining over the month and past 3 months. At a last close of US$9.74 and a market cap of about US$4.0b, the company is generating revenue of US$110.27m while reporting a net loss of US$141.39m. Reported annual revenue growth of 43.7% sits alongside net income growth of 25.7%. This helps frame how this autonomous...

Event driven snapshot of Albertsons Companies (ACI) Albertsons Companies (ACI) comes into focus after recent trading left the stock at $16.03, with returns down over the past week, month, past 3 months, year to date, and past year. See our latest analysis for Albertsons Companies. The recent 1 day share price gain of 1.91% comes after a period of weaker momentum, with the 90 day share price return down 9.94% and the 1 year total shareholder return down 25.12%, pointing to sentiment that has...

Ellomay Capital (NYSEAM:ELLO) opened 2026 with Q1 revenue of €8.7 million and a loss of €10.7 million in net income, which translated into basic EPS of a €0.78 loss, while trailing 12 month revenue stood at €42.6 million with a €19.7 million net loss and a basic EPS loss of €1.46. Over recent quarters, revenue has moved within a relatively tight band from €8.7 million to €11.3 million, while quarterly EPS has swung between a €0.85 loss and a €0.53 profit, underscoring how earnings are still...

Darden Restaurants recently reported past fiscal 2026 second-quarter results that were mixed, with earnings per share slightly beating expectations despite softer comparable sales and beef-driven cost inflation. The update underscored how Darden has been relying on pricing power, particularly in its higher-income steakhouse concepts, to help protect margins even as its longer-term revenue growth and gross margins remain relatively modest. We’ll now explore how this recent display of pricing...

Sociedad Química y Minera de Chile (NYSE:SQM) opened 2026 with Q1 revenue of about US$1.8 billion and basic EPS of US$1.28, setting a clear marker for how the year is starting. Over recent quarters, the company has seen revenue move from US$1,073.8 million in Q4 2024 to US$1,036.6 million in Q1 2025, then to US$1,760.0 million in Q1 2026. Over the same period, quarterly basic EPS shifted from US$0.42 to US$0.48 and then to US$1.28, giving investors a concrete view of how the top and bottom...

Exelixis (EXEL) has put fresh attention on its oncology pipeline after announcing extensive CABOMETYX and zanzalintinib data presentations at the 2026 ASCO meeting, along with a new colorectal cancer trial collaboration with Merck. See our latest analysis for Exelixis. The recent ASCO spotlight and Merck collaboration come after a strong run in the stock, with a 30 day share price return of 12.05% and a 3 year total shareholder return of 159.49%. This suggests that momentum has been building...